NitroMed Ramps Up For Solo BiDil Launch In July
This article was originally published in The Pink Sheet Daily
Executive Summary
NitroMed’s 190-person sales force has begun detailing the heart failure therapy, according to CEO Loberg. The firm expects to launch BiDil in two to four weeks, without a partner. Labeling provides defense against generic substitution, Loberg says.